Get started
Author

Marion Tina Weigel

Observed names: M Weigel, M. T. Weigel, M. Weigel, M.T. Weigel, Marion T Weigel, Marion T. Weigel, Marion Weigel
OpenAlex ID: A5020636985
Current and emerging biomarkers in breast cancer: prognosis and prediction
2010 · Marion T Weigel, Mitch Dowsett · Endocrine Related Cancer · 493
PDF
Vulvar cancer: epidemiology, clinical presentation, and management options
2015 · Ibrahim Alkatout, Veronika Günther, et al. · International Journal of Women s Health · 222
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
2006 · C. Bolling, T. Graefe, et al. · Investigational New Drugs · 77
Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma
2011 · Marion T. Weigel, Julia Krämer, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 62
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
2010 · Marion T Weigel, Linda Dahmke, et al. · BMC Cancer · 54
PDF
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles
2011 · Dirk O. Bauerschlag, Ole Ammerpohl, et al. · Oncology · 52
Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer
2012 · M.T. Weigel, S. Banerjee, et al. · Annals of Oncology · 44
PDF
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
2012 · Marion T Weigel, Zara Ghazoui, et al. · Breast Cancer Research · 44
PDF
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
2010 · Lesley-Ann Martin, Giles L. S. Davies, et al. · Breast Cancer Research and Treatment · 43
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo
2012 · Lesley-Ann Martin, Sunil Pancholi, et al. · Breast Cancer Research · 33
PDF
Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR β signalling
2008 · Marion T. Weigel, Ivo Meinhold-Heerlein, et al. · Cancer Letters · 30
Evaluation of Laparoscopy Virtual Reality Training on the Improvement of Trainees’ Surgical Skills
2021 · Mohamed Elessawy, Mohamed Mabrouk, et al. · Medicina · 27
PDF
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects
2008 · Christoph Mundhenke, Marion Tina Weigel, et al. · Journal of Cancer Research and Clinical Oncology · 27
Hysterectomy trends over a 9‐year period in an endoscopic teaching center
2014 · Thoralf Schollmeyer, Mohamed Elessawy, et al. · International Journal of Gynecology & Obstetrics · 25
Sunitinib (SU11248) inhibits growth of human ovarian cancer in xenografted mice.
2010 · Dirk O Bauerschlag, Christian Schem, et al. · PubMed · 25
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition
2011 · L.-A. Martin, Z. Ghazoui, et al. · Steroids · 21
Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer
2014 · Nicolai Maass, Christian Schem, et al. · Oncology · 19
Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.
2014 · Katharina Tiemann, Marion Tina Weigel, et al. · PubMed · 17
Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment
2014 · Marion T. Weigel, Katrin Rath, et al. · Oncology · 16
Combination of Enzastaurin and Pemetrexed Inhibits Cell Growth and Induces Apoptosis of Chemoresistant Ovarian Cancer Cells Regulating Extracellular Signal-Regulated Kinase 1/2 Phosphorylation
2009 · Karen Bräutigam, Dirk Olaf Bauerschlag, et al. · Translational Oncology · 16
PDF
Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer.
2010 · D O Bauerschlag, M Habermann, et al. · PubMed · 11
Leiomyomatosis peritonealis disseminata in a pregnant woman
2009 · Birte Summa, Christian Schem, et al. · Archives of Gynecology and Obstetrics · 9
The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer
2009 · Dirk O. Bauerschlag, Christian Schem, et al. · Journal of Cancer Research and Clinical Oncology · 8
Abstract 2920: Experimental and clinical studies reveal the PDGF/Abl pathway as a novel therapeutic target in endocrine-resistant breast cancer
2010 · Marion T. Weigel, Zara Ghazoui, et al. · Cancer Research · 2
Sectio caesarea (Kaiserschnitt)
2009 · N. Maass, M. T. Weigel · Springer eBooks · 2
Works count: 37
Citation count: 1,381
H-index: 17
I10-index: 21
Year
Topic
Type